Juvenile idiopathic arthritis: biologic disease modifying anti-rheumatic drugs
Pharmaceutical Journal,
After reading this article, you should be able to: Juvenile idiopathic arthritis (JIA) is the most common chronic childhood…
Tofacitinib dosing regimen established for pediatric testing
medwireNews,
medwireNews: Phase I study results suggest that the Janus kinase inhibitor tofacitinib is well tolerated in children with…